Leuprorelin acetate Prescribing at ROSLEA SURGERY
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
114
Total Quantity
114
NHS Cost
£23.0K
vs National Avg
+146%
ROSLEA SURGERY prescribed 114 items of Leuprorelin acetate over the last 12 months at a cost of £23,042 to the NHS. This is 146% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jun 2026
5
Jun 2026
10
Jun 2026
12
Jun 2026
10
Jun 2026
13
Jun 2026
8
Jun 2026
7
Jun 2026
10
Jun 2026
7
Jun 2026
10
Jun 2026
12
Jun 2026
10
Prescribing Details
| Total Items | 114 |
|---|---|
| Total Quantity | 114 |
| Total NHS Cost | £23,042 |
| Presentations | 2 different forms |
| vs National Average | +146% |
Leuprorelin acetate Prescribing Comparison
| This practice | 114 items |
|---|---|
| National average per practice | 46 items |
| Difference | +146% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.